MM+M editors Marc Iskowitz and Larry Dobrow interview people of note in and around the healthcare marketing world, and chat about news impacting the sector. New episodes to be released every Wednesday.
Three social-media experts – representing in-house, agency and platform – discuss leveraging social media to battle vaccine distrust, harnessing influencers and marketers’ likely use of the medium in 2021.
Hear about Spectrum’s involvement with the MM+M Pitch Slam, how to pitch virtually and why Spectrum is growing by leaps and bounds this year.
Dr. Charlotte Jones-Burton, VP of Otsuka and president and co-founder of WOCIP, weighs in on recent statements concerning Vice-President-elect Kamala Harris’ Black heritage, and offers her take on other news.
Dr. Patrice Harris speaks about what it was like to helm the American Medical Association for a one-year presidency that ended in June, as well as goals for her new role as medical editor-in-chief of Everyday Health.
With election results hanging in the balance a day after the US election, three A-list policy pros explain what we can expect for healthcare under two very different presidential scenarios.
In this sponsored podcast, Verywell general managers Rachel Berman and Rob Parisi discuss the evolving content needs of health and wellness consumers, the importance of transparency around diversity and inclusion, and the increasing role of empathy in health-related communication.
Quita Highsmith speaks about the biotech’s efforts to recruit and instill more trust among underserved and medically disenfranchised patients.
Deloitte’s David Betts and Chris Zant join MM+M’s Larry Dobrow to discuss the evolution in the way consultancies like Deloitte are working with life-sciences clients.
In this episode, Bakul Patel speaks about the agency’s new Digital Health Center of Excellence.
In this episode, Genevieve Paquette, Level Ex, discusses the state of the union for gamification efforts and the company’s new COVID-specific levels to its cardiology games.
Dan Trigub, former head of Uber Health who left on Sept. 8 to start his own healthcare company, returns to The MM+M Podcast to discuss his new firm, MedArrive.
Tamar Thompson, VP of government affairs and policy at Alexion Pharmaceuticals, speaks about how the biotech company has evolved on the D&I front.
Salvatore Paolozza, senior director, sales ops, Antares Pharma, speaks about ways he’s leveraged technology to ensure Antares’ reps maintain contact with doctors.
John Kenyon, head of Meredith’s Targeted Media Health unit, discusses the launch of People en Español Salud and the company’s huge investment in the point-of-care space.
Ethan Lindenberger talks about how COVID-19 has led to a surge in vaccine misinformation online, social media’s efforts to quell its spread and more.
Sebby Borriello, VP and chief commercial officer of SK Life Science, details his company’s experience launching Xcopri, an epilepsy drug, during the COVID-19 crisis.
PatientPoint’s Linda Ruschau shares her thoughts on the recent evolution of the point-of-care space.
Pascale Communications’ Amy Houck and Vivvi Britton join MM&M’s Larry Dobrow to discuss LinkedIn’s evolution as an A-list vehicle for health marketers.
Phreesia’s David Linetsky reveals how the point-of-care space adapted its offerings for the coronavirus era in this week’s episode of The MM&M Podcast.
WebMD’s Dr. John Whyte returns to The MM&M Podcast to discuss his company’s ongoing coverage of the COVID-19 pandemic.